Larotrectinib Genomic Testing Management and Overview

In an effort to promote higher quality patient care NCODA created the NCODA Positive Quality Intervention (PQI) as a peer-reviewed clinical guidance document for healthcare providers. By providing Quality Standards and effective practices around a specific aspect of cancer care, PQIs equip the entire multidisciplinary care team with a sophisticated yet concise resource for managing patients receiving oral or IV oncolytics. This PQI in Action is a follow up to the VITRAKVI® (larotrectinib) PQI and explores how the medically integrated teams at Florida Cancer Specialists and Indiana University Simon Cancer Center care for patients starting VITRAKVI® therapy. It will discuss how utilizing the Larotrectinib Genomic Management and Larotrectinib Overview PQIs can elevate patient care.